2GN-23362-40396
2 vaccinations
7 coded responses
24 check-ins
7 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 66+
- ZIP prefix
- 988 / WA
- Registered
- 2021-01-31
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-31
Registered in v-safe
-
2021-01-31
Dose 1 — Moderna
-
2021-01-31
Survey response — day 0, dose 1MedDRA: No adverse event — Feeling: Good · Site: ItchingFree text: NoMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-01
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-02-02
- 2021-02-03
- 2021-02-04
- 2021-02-05
- 2021-02-06
- 2021-02-07
- 2021-02-14
- 2021-02-21
-
2021-02-28
Dose 2 — Moderna
- 2021-02-28
-
2021-03-01
Survey response — days 1–6 daily, dose 2MedDRA: Dizziness — Feeling: Fair · Site: Pain, Swelling · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to do your normal daily activitiesFree text: DizzinessMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-02
Survey response — days 1–6 daily, dose 2MedDRA: Dizziness — Feeling: Fair · Site: Pain, Swelling · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Dizzimess; less than yesterdayMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-03
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Swelling, Itching · Fatigue or tiredness, Abdominal painAdult check-in
-
2021-03-04
Survey response — days 1–6 daily, dose 2MedDRA: Dizziness — Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: DizzinessMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-05
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Itching · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-06
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-07
Survey response — day 7, dose 2MedDRA: Head discomfort, Headache, Ocular discomfort — Feeling: GoodFree text: Finally back to normal. Headache this week was accompanied by head and eye pressure, now all resolved.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-14
- 2021-03-28
- 2021-04-04
- 2021-04-11
-
2021-05-31
Survey response — 3 months, dose 2MedDRA: Herpes zoster, Pelvic fracture, Pre-existing disease — Feeling: Fair · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visitFree text: Pelvic fracture from skiing accident 4/11/21 complicated by case of shingles.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-31
Report sent to call center — 3 months, dose 2Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2022-01-21
-
2022-02-28
Survey response — 12 months, dose 2MedDRA: COVID-19, Decreased appetite, Diarrhoea, Dizziness, Fatigue, Malaise, SARS-CoV-2 test negative, Taste disorder, Weight decreased — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Currently have probable covid despite 3 negative tests; now on 13th day. Symptoms: onset explosive diarrhea x 7 days Faint 1st night Deep malaise and fatigue Extreme taste changes No appetite; lost 10#MedDRA releases: 2024-11 · check-in free text available
-
2022-02-28
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-03-03
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-31 | Moderna | |
| 2 | 2021-02-28 | Moderna |
Call center
2 call center cases
2 unsuccessful
1 wait over 3 months for a first call
Free text
Release 3 — day 0, dose 1
Systemic reaction (other): No
Release 4 — days 1–6 daily, dose 2
Systemic reaction (other): Dizziness
Systemic reaction (other): Dizzimess; less than yesterday
Release 5 — days 1–6 daily, dose 2
Systemic reaction (other): Dizziness
Release 5 — day 7, dose 2
Systemic reaction (other): Finally back to normal. Headache this week was accompanied by head and eye pressure, now all resolved.
Release 8 — 3 months, dose 2
Symptoms: Pelvic fracture from skiing accident 4/11/21 complicated by case of shingles.
Release 11 — 12 months, dose 2
Symptoms: Currently have probable covid despite 3 negative tests; now on 13th day. Symptoms: onset explosive diarrhea x 7 days Faint 1st night Deep malaise and fatigue Extreme taste changes No appetite; lost 10#
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SD | Decreased appetite | · | · | ✓ |
| SD | Diarrhoea | · | · | ✓ |
| SD | Dizziness | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Herpes zoster | ✓ | ✓ | ✓ |
| SD | Malaise | · | · | ✓ |
| SD | Pelvic fracture | ✓ | ✓ | ✓ |
| SD | Pre-existing disease | ✓ | ✓ | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SD | Taste disorder | · | · | ✓ |
| SD | Weight decreased | · | · | ✓ |
| SRO | Dizziness | ✓ | ✓ | ✓ |
| SRO | Head discomfort | ✓ | ✓ | ✓ |
| SRO | Headache | ✓ | ✓ | ✓ |
| SRO | No adverse event | ✓ | ✓ | ✓ |
| SRO | Ocular discomfort | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release